Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways.
[severe combined immunodeficiency]
MiRNA-
34
a
is
considered
as
a
potential
prognostic
marker
for
glioma
,
as
studies
suggest
that
its
expression
negatively
correlates
with
patient
survival
in
grade
III
and
IV
glial
tumors
.
Here
,
we
show
that
expression
of
miR-
34
a
was
decreased
in
a
graded
manner
in
glioma
and
glioma
stem
cell-lines
as
compared
to
normal
brain
tissues
.
Ectopic
expression
of
miR-
34
a
in
glioma
stem
cell-lines
HNGC-
2
and
NSG-K
16
decreased
the
proliferative
and
migratory
potential
of
these
cells
,
induced
cell
cycle
arrest
and
caused
apoptosis
.
Notably
,
the
miR-
34
a
glioma
cells
formed
significantly
smaller
xenografts
in
immuno-
deficient
mice
as
compared
with
control
glioma
stem
cell-lines
.
Here
,
using
a
bioinformatics
approach
and
various
biological
assays
,
we
identify
Rictor
,
as
a
novel
target
for
miR-
34
a
in
glioma
stem
cells
.
Rictor
,
a
defining
component
of
mTORC
2
complex
,
is
involved
in
cell
survival
signaling
.
mTORC
2
lays
downstream
of
Akt
,
and
thus
is
a
direct
activator
of
Akt
.
Our
earlier
studies
have
elaborated
on
role
of
Rictor
in
glioma
invasion
(
Das
et
al
.
,
2011
)
.
Here
,
we
demonstrate
that
miR
34
a
over-expression
in
glioma
stem
cells
profoundly
decreased
levels
of
p
-
AKT
(
Ser
473
)
,
increased
GSK
-
3
β
levels
and
targeted
for
degradation
β-catenin
,
an
important
mediator
of
Wnt
signaling
pathway
.
This
led
to
diminished
levels
of
the
Wnt
effectors
cyclin
D
1
and
c-myc
.
Collectively
,
we
show
that
the
tumor
suppressive
function
of
miR-
34
a
in
glioblastoma
is
mediated
via
Rictor
,
which
through
its
effects
on
AKT
/
mTOR
pathway
and
Wnt
signaling
causes
pronounced
effects
on
glioma
malignancy
.
Diseases
Validation
Diseases presenting
"as studies suggest that its expression negatively correlates with patient survival in grade iii and iv glial tumors"
symptom
severe combined immunodeficiency
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom